President and CEO

Chief Financial Officer

StockWatch: After 1- and 6-Month Gains, Gene Editing Companies Await Q3 Results

Persistence Pays Off for Praxis as Essential Tremor Drug Succeeds in Two Pivotal Studies

Dow Dips Over 100 Points; US Crude Oil Inventories Surge

Praxis Precision surges, analysts see ‘blockbuster potential’ for ulixacaltamide

Express interest in future US-based positions

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders. They invite individuals to submit their resumes for future job opportunities, even if there are no current openings that fit their qualifications.

Sign up with Google

Sign in with Google